Cargando…
Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients
Invasive fungal infections (IFI) represent a major hindrance to the success of hematopoietic stem cell transplantation (HSCT), contributing substantially to morbidity and infection-related mortality. During the most recent years several reports indicate an overall increase of IFI among hematologic p...
Autores principales: | Busca, Alessandro, Pagano, Livio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016011/ https://www.ncbi.nlm.nih.gov/pubmed/27648202 http://dx.doi.org/10.4084/MJHID.2016.039 |
Ejemplares similares
-
Tuberculosis in Hematopoietic Stem Cell Transplant Recipients
por: Ramos, Jéssica Fernandes, et al.
Publicado: (2013) -
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
por: Lehrnbecher, Thomas, et al.
Publicado: (2020) -
Respiratory failure in the hematopoietic stem cell transplant recipient
por: Wieruszewski, Patrick M, et al.
Publicado: (2018) -
Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients
por: Balletto, Elisa, et al.
Publicado: (2015) -
Infection in the Hematopoietic Stem Cell Transplant Recipient
por: Marty, Francisco M., et al.
Publicado: (2008)